EKF Diagnostics Completes Share Buyback Programme
Why we think this is neutral
This RNS announcement provides an update on EKF Diagnostics' share buyback programme, which has now been completed. The announcement does not contain any of the mandatory news types specified, such as contract news, order news, trading updates, or financial results. As a result, the sentiment is considered neutral, as the news does not significantly impact the company's underlying business performance.
Key Points
- EKF Diagnostics has completed its share buyback programme, repurchasing over 4.6 million shares
- The shares were purchased at a weighted average price of 21.48 pence per share and will be held in treasury
Summary
The healthcare diagnostics company has completed its share buyback programme, repurchasing over 4.6 million shares.
EKF Diagnostics Holdings plc (AIM: EKF), the global diagnostics business, has announced the successful completion of its share buyback programme. The company repurchased a total of 4,636,774 ordinary shares at a weighted average cost of 21.48 pence per share. The shares purchased will be held in treasury.
GENERAL UPDATE